Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2007
07/03/2007US7238729 Silica mesoporous aerogels having three-dimensional nanoarchitecture with colloidal gold-protein superstructures nanoglued therein
07/03/2007US7238674 In situ injection; transduction; sustained release
07/03/2007US7238671 coadministration with and at least one therapeutic agent selected from the group consisting of an antidiabetic agent, an anti-obesity agent, a anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent
07/03/2007US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
07/03/2007US7238669 Phage-display peptides as novel antimicrobial agents against Haemophilus influenzae
07/03/2007US7238668 Exposing the lymphocytes to a peptide that binds to alpha 4 beta 1, consisting of three to twelve contiguous amino acid residues of the CS-1 region of fibronectin; suppression of the immune response
07/03/2007US7238667 Albumin fusion proteins
07/03/2007US7238662 Alpha 2HS glycoprotein for treatment of cancer and a method for preparation thereof
07/03/2007US7238660 Albumin fusion proteins
07/03/2007US7238659 Local, regionally-restricted delivery to an axon in situ of an ubiquitin-proteasome system inhibitor, optionally in conjunction with a microtubule stabilizing reagent, and detection the resultant reduction in axon trauma or axotomyn
07/03/2007US7238658 Treating agonist disorders including obesity, and hyperglycemic, whole body growth, immunological, kidney, neurological and neuromuscular disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern
07/03/2007US7238657 Cartilage/Bone inducing materials for preparation
07/03/2007US7238525 Inhibition of Bcr-Abl oncoprotein expression in cytoplasm by inducing translocation to the nucleus to activate the apoptotic pathway in cancer cells
07/03/2007US7238516 Method of hydrolyzing jojoba protein
07/03/2007US7238515 Anti-Listeria bacteriocin
07/03/2007US7238511 Preparation of deallergenized proteins and permuteins
07/03/2007US7238510 Glycoprotein synthesis
07/03/2007US7238507 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
07/03/2007US7238499 Trimeric macrophage scavenger receptor fusion proteins and encoding nucleic acids
07/03/2007US7238497 Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
07/03/2007US7238488 Therapeutic and diagnostic applications of perlecan domain I splice variants
07/03/2007US7238479 Single nucleotide polymorphism markers in the bovine CAPN1 gene to identify meat tenderness
07/03/2007US7238478 Compositions and methods for protein isolation
07/03/2007US7238475 Transgenic animal comprising apolipoprotein A-IV (APOAV) for diagnosing, evaluating and treating lipid-related, diabetic, cardiovascular and coronary diseases; insulin resistance; reduced triglycerides
07/03/2007US7238474 Materials and methods for detecting interaction of CFTR polypeptides
07/03/2007US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance
07/03/2007US7238358 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/03/2007US7238356 Core-glycosylated HCV envelope proteins
07/03/2007US7238354 Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain
07/03/2007US7238352 Methods and compositions for modulating tumor growth
07/03/2007US7238213 A combination of a fluorescent dye (especially a membrane potential dye or a calcium dye) and Nitrazine Yellow and Nitro Red as a quencher and its use in detecting the activity of a cyclic nucleotide-gated channel including detection of the G-protein-coupled receptor activity
07/03/2007CA2387755C Probe for constructing probe polymer, method of constructing probe polymer and utilization thereof
07/03/2007CA2361987C Goodpasture antigen binding protein
07/03/2007CA2359177C Bhv-1 gene-deleted virus vaccine
07/03/2007CA2333465C Growth differentiation factor promoter and uses therefor
07/03/2007CA2300681C Tolerance of trichothecene mycotoxins in plants and animals through the modification of the ribosomal protein l3 gene
07/03/2007CA2295199C Method for treating vascular proliferative diseases with p27 and fusions thereof
07/03/2007CA2288207C Specific gene activation by chimeric gal4 transcription factors in stable transgenic plants
07/03/2007CA2216611C Utrophin gene promoter
07/03/2007CA2158869C Recombinant virus, process for preparing the same and use thereof in gene therapy
07/03/2007CA2112676C Novel microorganism and insecticide
07/03/2007CA2092567C Nt-4 neurotrophic factor
06/2007
06/28/2007WO2007073411A1 Mcm6 and mcm7 monoclonal antibodies and methods for their use in the detection of cervical disease
06/28/2007WO2007073190A1 Recombinant gelatin particles for cell adhesion
06/28/2007WO2007073147A1 Apoptosis-inducing protein complexes and therapeutic use thereof
06/28/2007WO2007073137A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli
06/28/2007WO2007072997A1 Metastin derivatives and use thereof
06/28/2007WO2007072896A1 Method for prediction of prognosis of acute coronary syndrome
06/28/2007WO2007072037A1 Cyclic antimicrobial peptides
06/28/2007WO2007072032A2 Neisseria meningitidis vaccines and their use
06/28/2007WO2007072012A1 Novel members of the kazal family of serine protease inhibitors
06/28/2007WO2007072011A1 Interleukin- 9 like receptor protein
06/28/2007WO2007071996A2 Twin-arginine translocation (tat) streptomyces signal sequences
06/28/2007WO2007071994A2 Viral vectors
06/28/2007WO2007071992A1 Casein-like secreted protein
06/28/2007WO2007071850A2 Inhibition of the anti-fviii immune response
06/28/2007WO2007071768A1 Purification of proteins using preparative reverse phase chromatography (rpc)
06/28/2007WO2007071699A2 Methods for screening therapeutic efficacy of compositions in treatment of bone disease
06/28/2007WO2007071449A1 Soluble gp130 molecule variants useful as a medicament
06/28/2007WO2007071439A1 Soluble il-17rc variant and uses thereof
06/28/2007WO2007071248A2 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins
06/28/2007WO2007071068A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
06/28/2007WO2007071062A1 Methods and compositions for the detection and isolation of ligands
06/28/2007WO2007071051A1 Novel cancer-associated antigen
06/28/2007WO2007071045A1 Catecholamine regulated protein
06/28/2007WO2007071029A1 Hepatitis c virus ns2/3 assay
06/28/2007WO2007070996A2 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis
06/28/2007WO2007070960A1 Soybean nodulation factor receptor proteins, encoding nucleic acids and uses therefor
06/28/2007WO2007070936A1 Zinc transporter
06/28/2007WO2007070907A2 Therapeutic compositions
06/28/2007WO2007053952B1 Platelet factor-4 (pf-4) analogs and their use
06/28/2007WO2007051975A3 Compositions comprising igbpma and uses thereof
06/28/2007WO2007051626A3 Disease resistant plants
06/28/2007WO2007050569A3 Polypeptide multilayer films and methods
06/28/2007WO2007041645A3 Oxidized human bnp
06/28/2007WO2007040550A3 Torc polynucleotides and polypeptides, and methods of use
06/28/2007WO2007038564A3 Global transcription machinery engineering
06/28/2007WO2007026957A3 Glycerol channel gene and use thereof
06/28/2007WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza
06/28/2007WO2007017903A3 Expression vector and methods of producing high levels of proteins
06/28/2007WO2007014391A3 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
06/28/2007WO2007007362A3 Vegf-d and functional fragments thereof for bone repair
06/28/2007WO2007002069A3 Serum biomarkers for breast cancer
06/28/2007WO2006136450A3 Supravalent compounds
06/28/2007WO2006134340A3 Oxyntomodulin analogues and their effects on feeding behaviour
06/28/2007WO2006132701A3 Methods and kits for regulation of microtubule assembly and dendrite growth and branching
06/28/2007WO2006128593A3 Method for identifying fungicidally active compounds that are based on ipp isomerases
06/28/2007WO2006122205A3 Conus californicus neurotoxins
06/28/2007WO2006121464A3 Compositions for treating respiratory viral infections and their use
06/28/2007WO2006119388A3 Methods for the production of peptide having a c-terminal amide
06/28/2007WO2006119062A3 Sclerostin epitopes
06/28/2007WO2006035439A3 Recombinant human t2 rnase and uses thereof
06/28/2007WO2005113601A8 Antibodies and molecules derived therefrom that bind to steap-1 proteins
06/28/2007WO2005072419A3 Gastrointestinal proliferative factor and uses thereof
06/28/2007WO2005040194A3 Methods and compositions for pdgf-c activation and inhibition
06/28/2007WO2005028664A3 Modulation of programmed necrosis
06/28/2007WO2004075850A3 Polyvalent immunogen
06/28/2007WO2004010925A3 Mammalian genes involved in viral infection and tumor suppression
06/28/2007WO2002083919A3 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
06/28/2007WO2002070701A9 Novel human gnrh receptor